Analysis of cerebrospinal fluid cells by flow cytometry: Comparison to conventional cytology.


Journal

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
ISSN: 1804-7521
Titre abrégé: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
Pays: Czech Republic
ID NLM: 101140142

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 14 12 2021
accepted: 13 04 2022
medline: 15 6 2023
pubmed: 6 5 2022
entrez: 5 5 2022
Statut: ppublish

Résumé

This study compared the results obtained by basic immunophenotyping of cerebrospinal fluid (CSF) cells by flow cytometry (FC) to the results of conventional cytology and evaluated the possibility of detailed analyses of CSF B-cell subpopulations. Samples from 42 patients were examined by conventional cytology (native and/or pre-centrifuged CSF) and FC. The results from 15 patients without evidence of organic neurological disease were used to estimate reference ranges. Pre-centrifugated CSF had significantly higher cell yield on the cytologic slide, but cell subpopulation percentages were altered; the percentage of lymphocytes was significantly higher and monocytes significantly lower compared to both native CSF slides and FC. The percentage of granulocytes was higher in FC compared to cytology. For leukocyte count, the following reference ranges were estimated for Fuchs-Rosenthal chamber (FR) counting and FC, respectively: leukocytes ≤4.7/μL and ≤2.5/μL, lymphocytes ≤4.1/μL and ≤1.8/μL, monocytes ≤1.2/μL and ≤0.9/μL, and granulocytes 0/μL and ≤0.2/μL. The following reference ranges were estimated for basic subpopulations: T-lymphocytes 84.1-100%, B lymphocytes 0.0-1.5%, NK cells 0.0-6.3%, NKT cells 0-9.5%, and CD3+CD4+/CD3+CD8+ 0.8-4.9. Using a volume of 1.2-2.4 mL, the number of B lymphocytes was too low (<20) in samples with ≤2.7 cells/μL in the FR. Even normal CSF samples are amenable to basic mononuclear cell subpopulation analysis by FC. However, analysis of the B-cell subpopulations requires either a larger sample volume or selection of samples with ≥ 3 cells/μL.

Identifiants

pubmed: 35510294
doi: 10.5507/bp.2022.021
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-130

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Strik H, Nagel I. Cell count and staining. In: Deisenhammer F, Sellebjerg F, Teunissen CE, Tumani H (Eds.) Cerebrospinal fluid in clinical neurology. Springer, Cham 2015, ISBN 978-3-319-01224-7: pp. 81-100.
doi: 10.1007/978-3-319-01225-4_6
Tumani H, Petereit HF (Eds.) Lumbalpunktion und Liquordiagnostik. Guidelines of the German Society of Neurology, 2019. Available from: www.dgn.org [cited 2021 Dec 2]
Zeman D, Adam P, Kalistová H, Sobek O, Anděl J, Anděl M. Cerebrospinal fluid cytologic findings in multiple sclerosis. A comparison between patient subgroups. Acta Cytol 2000;45(1):51-9.
pubmed: 11213505 doi: 10.1159/000327187
Bielekova B, Pranzatelli MR. Promise, progress, and pitfalls in the search for central nervous system biomarkers in neuroimmunological diseases: A role for cerebrospinal fluid immunophenotyping. Semin Pediatr Neurol 2017;24:229-39.
pubmed: 29103430 doi: 10.1016/j.spen.2017.08.001
Alvermann S, Hennig C, Stüve O, Wiendl H, Stangel M. Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis. In search of biomarkers. JAMA Neurol 2014;71(7):905-12.
pubmed: 24818670 doi: 10.1001/jamaneurol.2014.395
Svenningsson A, Andersen O, Edsbagge M, Stemme S. Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J Neuroimmunol 1995;63:39-46.
pubmed: 8557823 doi: 10.1016/0165-5728(95)00126-3
de Graaf MT, Smitt PAES, Luitwieler RL, van Velzen C, van den Broek PDM, Kraan J, Gratama JW. Central memory CD4+ T cells dominate the normal cerebrospinal fluid. Cytometry Part B 2011;80B:43-50.
pubmed: 20632412 doi: 10.1002/cyto.b.20542
Han S, Lin YC, Wu T, Salgado AD, Mexhitaj A, Wuest SC, Romm E, Ohayon J, Goldbach-Mansky R, Vanderver A, Marques A, Toro C, Williamson P, Cortese I, Bielekova B. Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases. J Immunol 2014;192:2551-63.
pubmed: 24510966 doi: 10.4049/jimmunol.1302884
de Graaf MT, de Jongste AH, Kraan J, Boonstra JG, Sillevis Smitt PA, Gratama JW. Flow cytometric characterization of cerebrospinal fluid cells. Cytometry Part B 2011;80B:271-81.
pubmed: 21567940 doi: 10.1002/cyto.b.20603
Von Büdingen HC, Palanichamy A, Lehmann-Horn K, Michel BA, Zamvil SS. Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets. Eur Neurol 2015;73:238-46.
pubmed: 25824054 doi: 10.1159/000377675
De Graaf M, de Beukelaar J, Bergsma J, Kraan J, van den Bent M, Klimek M, van Norden Y, Kusuma A, Smitt PS, Gratama JW. B and T cell imbalances in CSF of patients with Hu-antibody associated PNS. J Neuroimmunol 2008;195:164-70.
pubmed: 18358542 doi: 10.1016/j.jneuroim.2008.01.007
Bojková J. [Methods used in cerebrospinal fluid cytology]. Bachelor thesis. University of Ostrava, Faculty of Medicine, defended 6. 6. 2013.
Juhásová D. [Possibilities of increase of cell count in cytological slide of cerebrospinal fluid.] Bachelor thesis. University of Ostrava, Faculty of Medicine, defended 31. 5. 2018.
Zeman D, Kušnierová P, Hradílek P, Čábal M, Zapletalová O. Oligoclonal IgG and free light chains - comparison between agarose and polyacrylamide isoelectric focusing. Cesk Slov Neurol N 2019;82/115(1):68-75.
doi: 10.14735/amcsnn201968
Zeman D, Kušnierová P, Všianský F, Reguliová K, Škutová M, Woznicová I, Zapletalová O, Hradílek P. Cerebrospinal fluid oligoclonal IgM test in routine practice: Comparison with quantitative assessment of intrathecal IgM synthesis. Clin Chim Acta 2020,508:137-45.
pubmed: 32416174 doi: 10.1016/j.cca.2020.05.021
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BM, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17(2):162-73.
pubmed: 29275977 doi: 10.1016/S1474-4422(17)30470-2
CLSI (2008). Defining, establishing and verifying reference intervals in the clinical laboratory: approved guideline - third edition. CLSI document C28-A3. Wayne, PA. Clinical and Laboratory Standards Institute.
Mix E, Olsson T, Correale J, Baig S, Kostulas V, Olsson O, Link H. B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol 1990;79:21-7.
pubmed: 1689227 doi: 10.1111/j.1365-2249.1990.tb05121.x
Reiber H. Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 1994,122:189-203.
pubmed: 8021703 doi: 10.1016/0022-510X(94)90298-4
Reiber H, Zeman D, Kušnierová P, Mundwiler E, Bernasconi L. Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams. Clin Chim Acta 2019;497:153-62.
pubmed: 31351929 doi: 10.1016/j.cca.2019.07.027
Rathbone E, Durant L, Kinsella J, Parker AR, Hassan-Smith G, Douglas MR, Curnow J. Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 2018; 89(10):1044-9.
pubmed: 29743290 doi: 10.1136/jnnp-2018-317947
Vafaii P, DiGiuseppe J. Detection of B-cell populations with monotypic light chain expression from patients with multiple sclerosis by polychromatic flow cytometry. Cytometry B Clin Cytom. 2014;86(2):106-10.
pubmed: 23818243 doi: 10.1002/cyto.b.21099
Kleine TO. Cellular immune surveillance of central nervous system bypasses blood-brain barrier and blood-cerebrospinal-fluid barrier: Revealed with the new Marburg cerebrospinal-fluid model in healthy humans. Cytometry A 2015;87A:227-43.
pubmed: 25641944 doi: 10.1002/cyto.a.22589
Kraan J, Gratama JW, Haioun C, Orfao A, Plonquet A, Porwit A, Quijano S, Stetler-Stevenson M, Subira D, Wilson W. Flow cytometric immunophenotyping of cerebrospinal fluid. Current Protocols in Cytometry 2008;6.24.1-6.25.16.
pubmed: 18770650 doi: 10.1002/0471142956.cy0625s45
Wurth S, Kuenz B, Bsteh G, Ehling R, Di Pauli F, Hegen H, Auer M, Gredler V, Deisenhammer F, Reindl M, Berger T. Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study. PLoS ONE 2017;12(8):e0182462.
pubmed: 28777826 doi: 10.1371/journal.pone.0182462
Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Frederiksen JL, Fleming JO, Furlan R, Hintzen RQ, Hughes SG, Johnson MH, Krasulova E, Kuhle J, Magnone MC, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Giovannoni G, Hemmer B, Tumani H, Deisenhammer F. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 2009;73:1914-22.
pubmed: 19949037 doi: 10.1212/WNL.0b013e3181c47cc2
Girard S, Fenneteau O, Mestrallet F, Troussard X, Lesesve JF. Recommandations pour l'analyse du liquide céphalorachidien au cours des leucémies aiguës. Ann Biol Clin 2017;75(5):503-12.
pubmed: 28853417 doi: 10.1684/abc.2017.1250
De Graaf MT, van den Broek PD, Kraan J, Luitwieler RL, van den Bent MJ, Boonstra JG, Schmitz PI, Gratama JW, Sillevis Smitt PA. Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over time. J Neurol 2011;258:1507-12.
pubmed: 21399987 doi: 10.1007/s00415-011-5970-8
Villar LM, Espiño M, Roldán E, Marín N, Costa-Frossard L, Muriel A, Álvarez-Cermeño JC. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes. Mult Scler 2011;17(6):690-4.
pubmed: 21436320 doi: 10.1177/1352458510396922
Jones AP, Kermode AG, Lucas RM, Carroll WM, Nolan D, Hart PH. Circulating immune cells in multiple sclerosis. Clin Exp Immunol 2016;187:193-203.
pubmed: 27689339 doi: 10.1111/cei.12878
Posová H, Horáková D, Čapek V, Uher T, Hrušková Z, Havrdová E. Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients. BMC Neurology 2017;17:145.
pubmed: 28754092 doi: 10.1186/s12883-017-0915-1
Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, Cesbron JY, Dumestre-Pérard C, Jacob MC. Novel strategy for phenotypic characterization of human B lymphocytes from precursors to effector cells by flow cytometry. PLoS ONE 2016;11(9):e0162209.
pubmed: 27657694 doi: 10.1371/journal.pone.0162209
Chovancová Z, Vlková M, Litzman J, Lokaj J, Thon V. Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination. Vaccine 2011;29(24):4142-50.
pubmed: 21473955 doi: 10.1016/j.vaccine.2011.03.087

Auteurs

David Zeman (D)

Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Institute of Laboratory Medicine, University Hospital Ostrava, Czech Republic.
Clinic of Neurology, University Hospital Ostrava, Czech Republic.

Kamila Revendova (K)

Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Clinic of Neurology, University Hospital Ostrava, Czech Republic.

Radovan Bunganic (R)

Clinic of Neurology, University Hospital Ostrava, Czech Republic.

Marketa Ryzi (M)

Institute of Laboratory Medicine, University Hospital Ostrava, Czech Republic.

Petra Masarovicova (P)

Institute of Laboratory Medicine, University Hospital Ostrava, Czech Republic.

Pavlina Kusnierova (P)

Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Institute of Laboratory Medicine, University Hospital Ostrava, Czech Republic.

Vera Kotrlova (V)

Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Institute of Laboratory Medicine, University Hospital Ostrava, Czech Republic.

Pavel Hradilek (P)

Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Clinic of Neurology, University Hospital Ostrava, Czech Republic.

David Stejskal (D)

Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Institute of Laboratory Medicine, University Hospital Ostrava, Czech Republic.

Vojtech Thon (V)

Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH